Investor Toolbox
Listen to Call
Recording not yet available.
Read Transcript
Transcript not yet available.
View Infographic
Infographic not yet available.
VTRS Coverage
Event
Viatris Inc (VTRS) Q4 2025 Earnings Results
Feb 26, 2026
Event
Viatris Inc (VTRS) Q4 2025 Earnings Call
Feb 26, 2026
Event
Viatris Inc (VTRS) FDA Accepts Viatris Supplemental New Drug Application for MR-141 (Phentolamine Ophthalmic Solution 0.75%) for the Treatment of Presbyopia
Feb 25, 2026
Transcript
Viatris Inc (VTRS) Q1 2021 Earnings Call Transcript
Jan 27, 2026
Transcript
Viatris Inc (VTRS) Q2 2025 Earnings Call Transcript
Jan 22, 2026
Transcript
Viatris Inc (VTRS) Q3 2025 Earnings Call Transcript
Jan 22, 2026
News
Viatris (VTRS) posts Q3 2025 results and updates 2025 guidance
Nov 6, 2025